Pharmaceutical products
Official WCO Harmonized System description: Vaccines; for human medicine
| Market | Importers | With contact | Above US$1M/yr | New in 2026 |
|---|---|---|---|---|
| 🇧🇷 Brazil | 9 | 5 | 1 | — |
These are companies with recorded import activity under this code — real buyers, not a directory of who might be interested. Captive assembly plants importing from their own parent abroad are identified separately, so the count you act on is commercial demand.
Every company that imported this heading in Mexico, the Dominican Republic, Colombia and Ecuador; Guatemala with partial coverage; Nicaragua, Bolivia, Peru, Uruguay and Argentina as emerging markets: who they are, who they buy from and at what price. One-off payment of US$ 1,490, delivered in 5 business days as PDF and Excel.
Measured channel: in heading 3002, 85% of 2025 value in Mexico, the Dominican Republic and Colombia goes through relationships with subsidiaries or captive or exclusive importers (heading screening). The report lists them all, marked 'subsidiary or exclusive'; they are not counted as multi-brand or as prospects.
Not ready to order? Write to hello@vstrade.co and we send you 3 importers of heading 3002 by name, free.
Sold and delivered by VS·Trade, the company behind WhoImports.
Every row is a real company recorded importing HS 3002.20. Registry information only: no import values, no individuals and no contact details are published on this page.
| Importing company | Location |
|---|---|
| Aventis Pharma Ltda. | 🇧🇷 SP |
| Baxter Hospitalar Ltda. | 🇧🇷 SP |
| Cristalia Produtos Químicos e Farmacêutico | 🇧🇷 SP |
| Daiichi Sankyo Brasil Farmacêutica Ltda. | 🇧🇷 PR |
| Fundação Butantan | 🇧🇷 SP |
| + 4 more companies recorded under this code | |
The figures above are counts. The annual report names the companies, who they buy from and at what price.
Order the annual report →Counts derived from customs operation records for Mexico and Argentina and from Brazil's public importers catalogue. Company names are registry information only: no import values, no individuals and no contact details are published on this page. See our methodology.